Pediatric Safety Evaluation of An AS-Adjuvanted H5N1 Prepandemic Candidate Vaccine in Children Aged 3-9 Years: A Phase II Study


Por: Ballester, A, Garces-Sanchez, M, Cantarino, M, Drame, M, Bouveret, N, Gillard, P and Diez-Domingo, J
Publicada: 1 dic 2008
Resumen:

ISSN: 12019712





INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Editorial
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, Países Bajos
Tipo de documento: Meeting Abstract
Volumen: 12 Número:
Páginas: 146-146
WOS Id: 000263287800363
imagen gold

MÉTRICAS